Will Fulgent Genetics Inc (FLGT) Outperform the Rest of the Stocks in the Healthcare Sector?

Fulgent Genetics Inc (FLGT) is around the top of the Healthcare sector according to InvestorsObserver. FLGT received an overall rating of 46, which means that it scores higher than 46% of stocks. Additionally, Fulgent Genetics Inc scored a 89 in the Healthcare sector, ranking it higher than 89% of stocks in that sector.

FLGT has an Overall Score of 46. Find out what this means to you and get the rest of the rankings on FLGT!

See Full FLGT Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Fulgent Genetics Inc Stock Today?

Fulgent Genetics Inc (FLGT) stock is down -0.28% while the S&P 500 is higher by 0.62% as of 1:41 PM on Tuesday, Jan 11. FLGT is down -$0.24 from the previous closing price of $84.95 on volume of 184,893 shares. Over the past year the S&P 500 is higher by 23.68% while FLGT is higher by 36.47%. FLGT earned $19.24 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 4.4. Click Here to get the full Stock Report for Fulgent Genetics Inc stock.